PharmChem, Inc. (PCHM) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate PharmChem, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
10.20
Strong
WeakModerateStrong
P/B Ratio
6.62
Weak
WeakModerateStrong
Earnings Yield
9.71%
Strong
WeakModerateStrong
Profitability Health
2024Return on Equity
64.26%
Strong
WeakModerateStrong
Operating Margin
27.33%
Strong
WeakModerateStrong
Net Profit Margin
22.69%
Strong
WeakModerateStrong
Growth Indicators
2024Revenue Growth
1.21%
Weak
WeakModerateStrong
Net Income Growth
63.38%
Strong
WeakModerateStrong
EPS Growth
76.47%
Strong
WeakModerateStrong
Efficiency & Liquidity
2024Current Ratio
4.70
Strong
WeakModerateStrong
Quick Ratio
4.30
Strong
WeakModerateStrong
Asset Turnover
2.23x
Strong
WeakModerateStrong
Inventory Turnover
9.69x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
9.16%
Strong
WeakModerateStrong
EV / Free Cash Flow
9.70x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.91x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.047
Strong
WeakModerateStrong
Return on Invested Capital
59.98%
Strong
WeakModerateStrong
Cash Conversion Cycle
49.91 days
Weak
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PCHM.
View Financial Statements